Ocugen-Bharat Biotech COVID-19 Vaccine Shows Immune Response, Meets Main Goals Of Trial In US

Reuters (1/9, Leo) reports, “Ocugen Inc said on Monday the COVID-19 vaccine developed by its Indian partner Bharat Biotech International Ltd met the main goals of a trial in the United States.” This “vaccine, sold under brand name Covaxin, showed an immun...